NeOnc Technologies Clinical Expansion Fund
Status
Active
Global HQ
Calabasas, United States
Countries of investment
- United States
Investment stages
- Series B
- Series C
Industries
- Oncology Biotech
About
NeOnc is a biotech-focused fund enabling novel cancer innovations. It supports clinical advancement toward regulatory milestones and commercialization.
NeOnc is a biotech-focused fund enabling novel cancer innovations. It supports clinical advancement toward regulatory milestones and commercialization.
Investment Thesis
Invests in oncology diagnostic and therapeutic startups at the clinical expansion stage.
Manager's Experience
Team invested in 15+ Web3 startups, with focus on blockchain protocol development. Crypto-focused with modest scale, not a top-tier player. Specialized crypto knowledge limits broader tech investment relevance.
Team
Amir Heshmatpour (Executive Chairman & President), Thomas Chen (CEO & CSO), Jimmy Delshad (Board Director), Dr. David Peereboom (Scientific Advisory Board)